ArticleBreast cancer research and treatment2015

Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.

Zhike Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.